Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
50.10
-41.39
-82.61%
Share Warrants & Outstandings
Total Reserve
5.54
-0.48
6.02
1,254.17%
Shareholder's Funds
14.25
49.62
-35.37
-71.28%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.21
0.00
3.21
0.00%
Secured Loans
0.66
0.00
0.66
0.00%
Unsecured Loans
2.55
0.00
2.55
0.00%
Deferred Tax Assets / Liabilities
-0.08
-0.30
0.22
73.33%
Other Long Term Liabilities
1.04
0.00
1.04
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.17
-0.17
-100.00%
Total Non-Current Liabilities
2.43
-0.12
2.55
2,125.00%
Current Liabilities
Trade Payables
1.85
2.12
-0.27
-12.74%
Other Current Liabilities
2.56
2.62
-0.06
-2.29%
Short Term Borrowings
7.70
9.75
-2.05
-21.03%
Short Term Provisions
0.00
2.28
-2.28
-100.00%
Total Current Liabilities
12.11
16.77
-4.66
-27.79%
Total Liabilities
28.79
66.27
-37.48
-56.56%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.76
121.07
-117.31
-96.89%
Less: Accumulated Depreciation
1.06
66.02
-64.96
-98.39%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.71
55.05
-52.34
-95.08%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
0.00
0.03
0.00%
Long Term Loans & Advances
0.02
0.78
-0.76
-97.44%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
2.75
55.83
-53.08
-95.07%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.21
1.82
4.39
241.21%
Sundry Debtors
16.13
0.04
16.09
40,225.00%
Cash and Bank
0.59
0.70
-0.11
-15.71%
Other Current Assets
1.13
2.98
-1.85
-62.08%
Short Term Loans and Advances
1.98
4.90
-2.92
-59.59%
Total Current Assets
26.05
10.44
15.61
149.52%
Net Current Assets (Including Current Investments)
13.93
-6.34
20.27
319.72%
Total Current Assets Excluding Current Investments
26.05
10.44
15.61
149.52%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.79
66.27
-37.48
-56.56%
Contingent Liabilities
3.37
0.00
3.37
0.00%
Total Debt
7.41
9.75
-2.34
-24.00%
Book Value per share (adjusted)
18.03
9.90
8.13
82.12%
Annual - Borrowings
Borrowings 9.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 26.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Footer loading
